Personalized cancer therapy – the key to the future
Author:
Affiliation:
1. Medical Solutions PLC, Imperial College, Hammersmith Hospital, London, UK; 79 Harley Street, London, W1G 8PZ, UK. karolsikora@hotmail.com
Publisher
Future Medicine Ltd
Subject
Pharmacology,Genetics,Molecular Medicine
Link
https://www.futuremedicine.com/doi/pdf/10.1517/phgs.5.3.225.29829
Reference10 articles.
1. Innovative cancer drug targets: genomics, transcriptomics and clinomics
2. Clinical implications of advanced molecular cytogenetics in cancer
3. The impact of pharmacogenetics and pharmacogenomics on drug discovery
4. Predictive Molecular Pathology
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of novel HER2 inhibitors against gastric cancer derived from flavonoid source of Syzygium alternifolium through molecular dynamics and pharmacophore-based screening;Drug Design, Development and Therapy;2016-11
2. Anti-cancer and Sensibilisation Effect of Triptolide on Human Epithelial Ovarian Cancer;Journal of Cancer;2016
3. Using Ontology Fingerprints to disambiguate gene name entities in the biomedical literature;Database;2015-04-08
4. Metabolomic studies of human gastric cancer: Review;World Journal of Gastroenterology;2014
5. Isolation of glioma cancer stem cells in relation to histological grades in glioma specimens;Child's Nervous System;2012-11-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3